NCT00775606 Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease Status TERMINATED Phase PHASE4
NCT00772902 ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial Status COMPLETED Phase PHASE4
NCT00768300 (ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF Status TERMINATED Phase PHASE3
NCT00757237 Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa Status COMPLETED Phase PHASE3
NCT00743795 Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection Status COMPLETED Phase PHASE2
NCT00743340 Rollover Study Protocol for Pediatric Patients in South Africa for Continued Access to Emtricitabine Status COMPLETED Phase PHASE2
NCT00740610 Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH) Status COMPLETED Phase PHASE2
NCT00737568 Tenofovir Disoproxil Fumarate (Tenofovir DF) Versus Emtricitabine/Tenofovir DF in Subjects Resistant to Lamivudine Status COMPLETED Phase PHASE3
NCT00736190 A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection Status COMPLETED Phase PHASE4
NCT00734162 Evaluation of Tenofovir Disoproxil Fumarate in Adolescents With Chronic Hepatitis B Infection Status COMPLETED Phase PHASE3
NCT00725803 Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV Status COMPLETED Phase PHASE2
NCT00724711 Safety and Efficacy Study of Switching From Epzicom to Truvada Status COMPLETED Phase PHASE4
NCT00712166 Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa Status COMPLETED Phase PHASE3
NCT00710528 Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies Status COMPLETED Phase PHASE1
NCT00708162 Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir Status COMPLETED Phase PHASE3
NCT00701883 Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High Cholesterol Status COMPLETED Phase PHASE2
NCT00697944 Ambisome® Preemptive Treatment of Multiple Candida Colonization in Sepsis Patients Status UNKNOWN Phase PHASE4